Correction To: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence Into Practice

Diabetes Therapy - United States
doi 10.1007/s13300-019-0670-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Translating Evidence Into Clinical Practice

Advances in Pulmonary Hypertension
2009English

Translating Research Into Evidence-Based Practice

Cancer
Cancer ResearchOncology
2010English

Evidence‐based Practice in Nutrition and Dietetics: Translating Evidence Into Practice

Nutrition and Dietetics
NutritionDietetics
2019English

Improving Quality in Healthcare: Translating Evidence Into Practice

Evidence-Based Dentistry
Dentistry
2013English

Translating Theories Into Practice

The Singapore Family Physician
2019English

Translating Research Into Practice

Medical Care
EnvironmentalPublic HealthOccupational Health
2012English

SGLT2 Inhibitors for Primary Prevention of Cardiovascular Events

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Going Beyond HbA1C to Understand the Benefits of Advanced Diabetes Therapies

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

SGLT2 Inhibitors

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy